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Carotid artery stenting is an increasingly used treatment for
carotid artery stenosis [1–3]. The complications include minor and
major stroke and peri-interventional death [4]. Stent thrombosis is
rarely reported to occur during the treatment of carotid stenosis, and
there has been one report on the successful use of a glycoprotein IIb/
IIIa antagonist [5].
Case Report
A 76-year-old man was admitted with symptoms consistent with
a right middle cerebral artery (MCA) infarction. He was on his way
home from a surgical ward, where he had received a stent 4 days
before. The stent had been placed in the right internal carotid artery
(ICA) to treat a 70% ICA stenosis which produced right-sided amau-
rosis fugax. The patient had had two previous endarterectomies on
the same side. Immediately after stenting, which was confirmed to be
successful by angioscopy, the patient received aspirin and intrave-
nous heparin. His postoperative course was uneventful. It was
planned to maintain the patient on 300 mg aspirin daily, but on hos-
pital discharge he had been given neither anticoagulation nor aspirin
by mistake. The treatment regimen at that time did not include clopi-
dogrel. The neurological examination showed hemiparesis, hemine-
glect and hemianopia on the left side (NIHSS 16). The color-coded
duplex sonography showed a thrombotic occlusion of the stented
right ICA (fig. 1a) and an occlusion of the right MCA. Cranial com-
puted tomography only revealed on old, right-sided posterior wa-
tershed infarct (fig. 2). The acute thrombosis of the stent was thought
to be the source of an embolism of the right MCA. Since the patient
fulfilled the criteria for intravenous thrombolysis, we started intrave-
nous thrombolysis 2 h after the initial symptoms, using 70 mg rt-PA.
Besides the thrombolysis, the patient immediately received intrave-
nous heparin. The patient started to improve 30 min after initiation
of thrombolysis. An ultrasound examination 1 h after the thromboly-
sis revealed an open stent (see fig. 1b) and restored normal right
MCA blood flow velocity. The patient was discharged 5 days later.
He still had a slight motor deficit (NIHSS 2), but a score of 1 on the
Rankin scale and a Barthel index of 100.
Discussion
While stenting is widely used in cardiology, only limited experi-
ence has been gathered on its use in carotid artery disease [1, 2].
About 5,210 procedures have been reported worldwide (technical
success rate 98.4%; transient ischemic attacks 2.82%, minor strokes
2.72%, major strokes, 1.49%; deaths 0.86%) [1]. Various clinical
trials are being planned or are in progress to establish the indications
for carotid artery stenting (CREST, SPACE, CASET) [6]. Recently,
the Carotid and Vertebral Artery Transluminal Angioplasty Study
(CAVATAS) demonstrated similar 3-year results for endovascular
treatment and carotid endarterectomy for major risks and effective-
ness, and avoidance of minor complications [7]. Stent thrombosis is a
well-known problem in cardiology [8]. A thrombosis rate of 3.5% was
reported as a first result [8]. Aggressive antiplatelet therapy, includ-
ing the combined use of ticlopidin or clopidogrel and aspirin, reduces
the rate of stent thrombosis to approximately 1% [8]. Platelet activa-
tion and aggregation may play a relevant role in the treatment of
thrombotic occlusion of stented vessel segments [9]. Abciximab has
been proposed in carotid stenting to prevent rethrombosis [9]. The
treatment of early intracoronary stent thrombosis includes balloon
angioplasty and intracoronary thrombolysis. Systemic thrombolysis
has so far been attempted as a second therapeutic alternative [10].
We performed an intravenous rt-PA thrombolysis similar to the
known NINDS protocol to reperfuse the MCA. In contrast to this
protocol, heparin was given early because we hoped it would prevent
another thrombosis, and indeed both the MCA and the thrombosed
stent were recanalized. Thus, thrombolysis was able to dissolve a
large thrombus in the stent and an embolus in the MCA. After the
intervention, we discovered a recent case report about the intrave-
nous administration of a glycoprotein IIb/IIIa receptor antagonist to
recanalize acute stent thrombosis [7]. To the best of our knowledge,
this is the first report of the use of intravenous thrombolysis to suc-
cessfully recanalize a carotid stent thrombosis with concomitant
embolic MCA occlusion. Obviously, this single case can only help to
illuminate the available treatment options rather than provide gener-
al therapeutic recommendations.
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Fig. 1. a Color-coded duplex sonography of the right ICA demonstrating the thrombotic
occlusion of this vessel (arrow) before treatment. b Color-coded duplex sonography of the
right ICA after systemic thrombolysis showing the restored blood flow and the reopened
vessel.
Fig. 2. Cranial computed tomography 1 h
after the onset of initial symptoms of an
acute MCA right-sided stroke. No early signs
of infarction were detected, but an old wa-
tershed infarction (arrow) is visible between
the territory of the MCA and the posterior
cerebral artery on the right side. Courtesy of
Prof. Brückmann, Head Institute of Neuro-
radiology, Ludwig Maximilian University,
Munich, Germany.
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